pixel Skip to Main Content
Everself Everself

Scientific Advisory Board

Meet our esteemed advisors advancing endoscopic weight loss treatments.

Endoscopic weight loss procedures represent a rapidly evolving field. One of the most promising treatments, ESG Stomach Tightening®, only received FDA authorization in 2022. The intricacies of suturing techniques, the integration of these procedures with medications, and their impact on other health conditions such as diabetes and fatty liver disease, continue to be focal points of research at leading institutions.

Since physicians often have varying approaches to ESG and other endoscopic treatments, it’s crucial to establish standardized protocols based on the latest scientific findings. These protocols range from pre-procedure medical assessments to specific suturing techniques, post-procedure aftercare, and the incorporation of anti-obesity medications.

In light of this dynamic landscape, Bariendo has convened a Scientific Advisory Board composed of preeminent researchers in the field to guide our operations.

Bariendo is now Everself.

Since pioneering ESG at Harvard over a decade ago, we've helped thousands achieve life-changing, long-lasting weight loss. Our new name and brand reflect what we've always stood for: helping you become ever healthy, ever confident, ever yourself.

Enter Site